These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31227789)

  • 1. New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy.
    Saw M; Wong VW; Ho IV; Liew G
    Eye (Lond); 2019 Dec; 33(12):1842-1851. PubMed ID: 31227789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of rosiglitazone and macular oedema in patients with type 2 diabetes mellitus.
    Tatti P; Arrigoni F; Longobardi A; Costanza F; Di Blasi P; Merante D
    Clin Drug Investig; 2008; 28(5):327-32. PubMed ID: 18407718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Stratton IM; Matthews DR
    Diabet Med; 1997 Aug; 14(8):709-10. PubMed ID: 9272603
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.
    Keech AC; Mitchell P; Summanen PA; O'Day J; Davis TM; Moffitt MS; Taskinen MR; Simes RJ; Tse D; Williamson E; Merrifield A; Laatikainen LT; d'Emden MC; Crimet DC; O'Connell RL; Colman PG;
    Lancet; 2007 Nov; 370(9600):1687-97. PubMed ID: 17988728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLP-1R as a Target for the Treatment of Diabetic Retinopathy: Friend or Foe?
    Simó R; Hernández C
    Diabetes; 2017 Jun; 66(6):1453-1460. PubMed ID: 28533296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on "New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy".
    Xiao G; Li AS
    Eye (Lond); 2021 Oct; 35(10):2903-2904. PubMed ID: 33005047
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of proliferative diabetic retinopathy with insulin use and microalbuminuria.
    Chu SH; Li AH
    Arch Ophthalmol; 2010 Jan; 128(1):146; author reply 146-7. PubMed ID: 20065240
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe macular edema induced by pioglitazone in a patient with diabetic retinopathy: a case study.
    Oshitari T; Asaumi N; Watanabe M; Kumagai K; Mitamura Y
    Vasc Health Risk Manag; 2008; 4(5):1137-40. PubMed ID: 19183764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications.
    Alcubierre N; Rubinat E; Traveset A; Martinez-Alonso M; Hernandez M; Jurjo C; Mauricio D
    Health Qual Life Outcomes; 2014 Aug; 12():131. PubMed ID: 25138117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 receptor agonists and microvascular outcomes in type 2 diabetes: A systematic review and meta-analysis.
    Avgerinos I; Karagiannis T; Malandris K; Liakos A; Mainou M; Bekiari E; Matthews DR; Tsapas A
    Diabetes Obes Metab; 2019 Jan; 21(1):188-193. PubMed ID: 30058208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.
    Beulens JW; Patel A; Vingerling JR; Cruickshank JK; Hughes AD; Stanton A; Lu J; McG Thom SA; Grobbee DE; Stolk RP; ;
    Diabetologia; 2009 Oct; 52(10):2027-36. PubMed ID: 19633827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults.
    Wang T; Hong JL; Gower EW; Pate V; Garg S; Buse JB; Stürmer T
    Diabetes Care; 2018 Sep; 41(9):1998-2009. PubMed ID: 30012674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Nreu B; Scatena A; Andreozzi F; Sesti G; Mannucci E; Monami M
    Acta Diabetol; 2017 Oct; 54(10):933-941. PubMed ID: 28748377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic retinopathy in a remote Indigenous primary healthcare population: a Central Australian diabetic retinopathy screening study in the Telehealth Eye and Associated Medical Services Network project.
    Brazionis L; Jenkins A; Keech A; Ryan C; Brown A; Boffa J; Bursell S;
    Diabet Med; 2018 May; 35(5):630-639. PubMed ID: 29405370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the use of a scanning laser-derived oedema index to grade diabetic retinopathy and maculopathy.
    Styles CJ; Park SJ; McGhee CN; Gamble G; Donaldson ML
    Clin Exp Ophthalmol; 2007; 35(1):18-23. PubMed ID: 17300566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic macular oedema: under-represented in the genetic analysis of diabetic retinopathy.
    Broadgate S; Kiire C; Halford S; Chong V
    Acta Ophthalmol; 2018 Apr; 96 Suppl A111():1-51. PubMed ID: 29682912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor glycaemic control and retinopathy in non-insulin-dependent diabetes mellitus.
    Bastyr EJ; Janes J; Barnett AH
    Diabet Med; 1997 Nov; 14(11):993-4. PubMed ID: 9400930
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy.
    Douros A; Filion KB; Yin H; Yu OH; Etminan M; Udell JA; Azoulay L
    Diabetes Care; 2018 Nov; 41(11):2330-2338. PubMed ID: 30150234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema.
    Boehm BO; Schilling S; Rosinger S; Lang GE; Lang GK; Kientsch-Engel R; Stahl P
    Diabetologia; 2004 Aug; 47(8):1376-9. PubMed ID: 15258735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic retinopathy and insulin glargine.
    Chantelau E
    Diabetologia; 2009 Oct; 52(10):2233; author reply 2236-9. PubMed ID: 19680626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.